Internet Claims Regarding SARS Prevention Provoke Warning Letters
This article was originally published in The Gray Sheet
Executive Summary
Eight manufacturers and distributors will receive 1warning letters, following a coordinated effort by the Federal Trade Commission, the FDA and the Ontario Ministry of Consumer and Business Services to "surf" the Internet for false and misleading claims related to Severe Acute Respiratory Syndrome
You may also be interested in...
Serious Disease Genetic Testing Claims More Likely To Prompt FTC Action
The Federal Trade Commission's limited oversight of regional laboratories and genetic test promotional claims for non-life-threatening diseases is eliciting concern from the HHS Secretary's Advisory Committee on Genetics, Health & Society
Serious Disease Genetic Testing Claims More Likely To Prompt FTC Action
The Federal Trade Commission's limited oversight of regional laboratories and genetic test promotional claims for non-life-threatening diseases is eliciting concern from the HHS Secretary's Advisory Committee on Genetics, Health & Society
CDRH More Reliant On SEC, FTC For Ad/Promotion Vigilance Under Policy Shift
The Center for Devices & Radiological Health increasingly is looking to other federal agencies to help regulate medical device advertising and promotion as it scales back its own claim enforcement activities